HBCN — Healthbeacon Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Healthbeacon, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.35 | 1.58 | 1.21 | 2.21 | 2.25 |
| Cost of Revenue | |||||
| Gross Profit | 0.881 | 0.919 | 0.667 | 0.301 | 0.136 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.05 | 4.17 | 4.63 | 9.51 | 15.4 |
| Operating Profit | -1.7 | -2.6 | -3.42 | -7.3 | -13.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.41 | -2.62 | -3.43 | -8.21 | -13.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.41 | -2.62 | -3.43 | -8.21 | -13.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.41 | -2.62 | -3.43 | -8.21 | -13.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.41 | -2.62 | -3.43 | -8.21 | -13.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.142 | -0.155 | -0.195 | -0.483 | -0.785 |
| Dividends per Share |